Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Colistimethate sodium/Colistin sulfomethate sodium

Brand: Colomycin┬«
NICE TA: 
Indication: Non-cystic fibrosis bronchiectasis
Disease category: Infections
Commissioning responsibility: CCG
PbR excluded: No

Background

Colistimethate sodium (Colomycin®) is recommended as an option for patients with non-cystic fibrosis bronchiectasis, colonised with Pseudomonas aeruginosa who have three or more exacerbations per year requiring antibiotics or fewer exacerbations that are causing significant morbidity, in whom long term nebulised antibiotic therapy is being considered.

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

LMMG New Medicines Assessment - Colomycin in Non-CF Bronchiectasis

Nebulised Colomycin Prescribing Information Sheet Non-CF Indications (Version 1.1) (151.2 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber

Amber

Amber0

Amber0

Amber0

Red